We serve Chemical Name:1-[4-Nitro-3-(trifluoromethyl)phenyl]piperazine CAS:153204-82-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-[4-Nitro-3-(trifluoromethyl)phenyl]piperazine
CAS.NO:153204-82-1
Synonyms:1-[4-nitro-3-(trifluoromethyl)phenyl]piperazine
Molecular Formula:C11H12F3N3O2
Molecular Weight:275.22700
HS Code:2933599090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:411.4ºC at 760mmHg
Density:1.355g/cm3
Index of Refraction:1.515
PSA:61.09000
Exact Mass:275.08800
LogP:2.94020
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-[4-nitro-3-(trifluoromethyl)phenyl]piperazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-[4-nitro-3-(trifluoromethyl)phenyl]piperazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-[4-nitro-3-(trifluoromethyl)phenyl]piperazine Use and application,1-[4-nitro-3-(trifluoromethyl)phenyl]piperazine technical grade,usp/ep/jp grade.
Related News: Results from a Phase I clinical trial, published in The Lancet, found that two-doses of the inhaled Ad5-nCoV vaccine can trigger a similar immune response to a single-dose of the injected version. N-{4-[4-hydroxy-3-(pyrrolidine-1-sulfonyl)-phenoxy]-3,5-dimethyl-phenyl}-oxamic acid ethyl ester manufacturers For skin rash, the difference in response rates for anifrolumab versus placebo at week 52 were 13.5% SLE Disease Activity Index (SLEDAI), 15.5% British Isles Lupus Assessment Group index (BILAG) and 15.6% modified Cutaneous Lupus Erythematosus Disease Area and Severity Index (mCLASI). For arthritis, differences in response rates were 8.2% SLEDAI, 11.8% BILAG and 12.6% joint response. 1,2-Benzenediol, 4-[2-[[6-[(2-phenylethyl)thio]hexyl]amino]ethyl]-,hydrochloride suppliers Such investment is by no means prohibitive and can reap substantial rewards that include shorter development timelines, lower costs, faster time to market, and game changing technological advantage for sustainable competitive edge. 4-Methyl-N-[1-(4-oxo-cyclohexa-2,5-dienylideneamino)-1-phenyl-meth-(Z)-ylidene]-benzenesulfonamide vendor & factory.